Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cardiovascular Systems (CSII) stocks in Canada

Learn how to easily invest in Cardiovascular Systems stocks.

Cardiovascular Systems is a medical devices business based in the US. Cardiovascular Systems stocks (CSII.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $42.74 – a decrease of 2.07% over the previous week. Cardiovascular Systems employs 780 staff and has a trailing 12-month revenue of around $244.7 million.

How to buy stocks in Cardiovascular Systems

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CSII – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cardiovascular Systems stock price (NASDAQ:CSII)

Use our graph to track the performance of CSII stocks over time.

Cardiovascular Systems shares at a glance

Information last updated 2022-05-20.
Latest market close$15.61
52-week range$14.12 - $44.57
50-day moving average $19.65
200-day moving average $24.98
Wall St. target price$22.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.84

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Cardiovascular Systems stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Cardiovascular Systems price performance over time

Historical closes compared with the close of $15.61 from 2022-05-20

1 week (2022-05-11) N/A
1 month (2022-04-20) -28.53%
3 months (2022-02-18) -17.06%
6 months (2021-11-22) -34.77%
1 year (2021-05-21) -59.49%
2 years (2020-05-22) -57.82%
3 years (2019-05-22) 39.64
5 years (2017-05-22) 31.61

Is Cardiovascular Systems under- or over-valued?

Valuing Cardiovascular Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cardiovascular Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cardiovascular Systems's PEG ratio

Cardiovascular Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 177.27. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cardiovascular Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Cardiovascular Systems's EBITDA

Cardiovascular Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.6 million.

The EBITDA is a measure of a Cardiovascular Systems's overall financial performance and is widely used to measure a its profitability.

Cardiovascular Systems financials

Revenue TTM $244.7 million
Gross profit TTM $197.8 million
Return on assets TTM -5.82%
Return on equity TTM -12.42%
Profit margin -13.29%
Book value $6.22
Market capitalisation $601.2 million

TTM: trailing 12 months

Cardiovascular Systems share dividends

We're not expecting Cardiovascular Systems to pay a dividend over the next 12 months.

Have Cardiovascular Systems's shares ever split?

Cardiovascular Systems's shares were split on a 1:10 basis on 26 February 2009. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cardiovascular Systems shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Cardiovascular Systems shares which in turn could have impacted Cardiovascular Systems's share price.

Cardiovascular Systems share price volatility

Over the last 12 months, Cardiovascular Systems's shares have ranged in value from as little as $14.12 up to $44.57. A popular way to gauge a stock's volatility is its "beta".

CSII.US volatility(beta: 0.91)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cardiovascular Systems's is 0.9054. This would suggest that Cardiovascular Systems's shares are less volatile than average (for this exchange).

Cardiovascular Systems overview

Cardiovascular Systems, Inc. , a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company has a partnership with Chansu Vascular Technologies, LLC to develop peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site